金融界8月18日消息，周一港股集体高开，盘面上，大型科技股多数走高，截至10：55，港股科技 50ETF(513980)涨1.40%，该基金年内至今已涨超46%！ 港股科技50ETF(513980)紧密跟踪中证港股通科技指数，成分股涵盖小米集团-W、阿里巴巴等一众港股 电子行业龙头，前十大权重股权重合计约66%。当前港股科技50ETF（513980）基金规模190亿，在跟 踪同指数ETF基金中规模第一。 看好港股科技股，不妨关注港股科技50ETF(513980)及其联接基金（A类：016495；C类：016496），助 力布局港股优质资产赛道。 风险提示：文中提及的指数成份股仅作展示，个股描述不作为任何形式的投资建议。任何在本文出现的 信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，投资 人须对任何自主决定的投资行为负责。基金投资有风险，基金的过往业绩并不代表其未来表现，基金管 理人管理的其他基金的业绩并不构成基金业绩表现的保证，基金投资须谨慎。 本文源自：金融界 作者：E播报 热门个股方面，长城汽车涨超10%，中兴通讯涨超9%，京东健康、商汤-W、瑞声科技等涨超4%，信 ...

Group 1 - The core viewpoint of the articles highlights a positive trend in the Hong Kong stock market, particularly in technology and pharmaceutical sectors, with significant gains observed in the Hong Kong Technology 50 ETF and various individual stocks [1][2] - The Hong Kong Technology 50 ETF (513980) has seen a year-to-date increase of over 32%, with a recent trading volume of 5.07 billion yuan and a net inflow of 62.05 billion yuan since the beginning of the year [1] - Major stocks in the innovation drug sector have shown strong performance, with notable increases such as Genscript Biotech rising over 14% and 3SBio increasing over 7% [1] Group 2 - According to Huatai Securities, the recent positive signals from the US-China summit may reduce tariff friction, potentially enhancing China's growth expectations and providing upward momentum for the renminbi and its assets [1] - Industrial growth is anticipated to focus on technology, particularly the AI industry chain, with an emphasis on upstream computing power and downstream application innovation [2] - The Hong Kong Technology 50 ETF is the largest in its category, with a fund size of 135.99 billion yuan, reflecting the performance of leading companies in internet, new energy vehicles, and biomedicine sectors [2]

看好港股科技发展前景，不妨关注港股科技50ETF(513980)及其联接基金（A类：016495；C类： 016496），助力布局港股优质资产赛道。 来源：金融界 金融界5月6日消息，周二开盘港股迎来五月假期后"开门红"，三大指数集体走强，盘面上，DeepSeek及 黄金概念股普涨，截至10：35，港股科技50ETF(513980)涨2.33%。 消息面上，近期港币汇率持续走强，逼近 7.75 的联系汇率上限，香港金融管理局（HKMA）多次干预 以平衡汇率，背后或折射出国际资本对港股资产的强烈配置需求。在香港房地产市场仍处调整期的背景 下，资金集中流向港股科技及互联网板块的趋势显著。 根据国泰海通证券统计，2024年港股净利润增速继续回升。2024年全部港股归母净利润累计同比为 9.8%，其中，上半年/下半年同比分别为7.5%/13.3%，下半年港股净利润增速大幅上行。该机构认为， 展望未来，尽管外部环境或有阶段性扰动，但国内政策发力背景下经济望维持韧性，叠加科技周期回 升，预计港股盈利增速维持高位。 截至最新，港股科技50ETF（513980）基金规模144亿元，在跟踪同指数ETF基金中规模第一！港股科 技 ...

Core Viewpoint - The Hong Kong stock market is gradually stabilizing and rebounding as the impact of tariffs diminishes, with significant gains in major indices, particularly in technology and consumer sectors [1][2]. Group 1: Market Performance - As of April 23, the Hang Seng Technology Index rose by 2.84%, the Hang Seng Index by 2.11%, and the Hang Seng China Enterprises Index by 1.83% [1]. - Since March 20, the Hong Kong stock market has experienced continuous adjustments, but has begun to recover due to interventions from state-owned enterprises [2]. Group 2: Investment Opportunities - The Hong Kong stock market is seeing a growing proportion of technology and new consumer companies, which are expected to account for 54.5% of the total market capitalization by the end of 2024 [2]. - ETFs focusing on technology, consumption, and innovative pharmaceuticals are becoming popular among investors, providing efficient access to these sectors [1][3]. Group 3: Specific ETF Products - The Hong Kong Technology 50 ETF (513980) targets large-cap technology leaders with high R&D investment and revenue growth, including companies like Meituan and Tencent [2]. - The Hang Seng Consumption ETF (513970) focuses on essential and discretionary consumer goods, excluding alcohol and internet platforms, aiming to capture opportunities in consumer recovery [3]. - The Hong Kong Innovative Drug 50 ETF (513780) tracks leading companies in the innovative pharmaceutical sector, which is relatively scarce compared to the A-share market [3].